Design, development and optimisation of irinotecan human serum albumin nanoparticles

• In: Poster Presentation
• At: Stockholm (Sweden) (2017)
• Type: Poster
• Poster code: P-C-027-Tuesday
• By: SINGH, Kamalinder K (University of Central Lancashire, School of Pharmacy and Biomedical Sciences, Preston, United Kingdom)
• Co-author(s): Neetika Taneja: CU Shah College of Pharmacy, SNDT Women's University, Mumbai, India
  Kamalinder K Singh: School of Pharmacy and Biomedical Sciences, University of Central Lancashire, Preston, United Kingdom;CU Shah College of Pharmacy, SNDT Women's University, Mumbai, India
  
• Abstract:

  Backgrounds

  Human serum albumin(HSA) is emerging as a potential protein carrier for several drugs because of its advantages including non-immunogenicity, biodegradability and non-toxic nature. Irinotecan(Iro) is first line treatment of metastatic colorectal cancer.

  Aims

  The aim of present research was to prepare and optimize irinotecan loaded

  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login